BioSpace News Archive

Octapharma is pleased to announce that the U.S. Food and Drug Administration (FDA) has approved an updated Prescribing Information (PI) for NUWIQ®, Octapharma’s human cell line-derived recombinant factor VIII (FVIII). NUWIQ ® is approved for the prevention and treatment of bleeding in people with haemophilia A.

The Alzheimer Society of Canada welcomes the appointment of Dr. Saskia Sivananthan to the Ministerial Advisory Board on Dementia.

More than 2000 delegates representing cardiologists, cardiovascular surgeons, researchers, nurses and other cardiovascular specialists from across Canada and around the globe will gather virtually to share and learn of the latest in cardiovascular health and care.

The Barbara Ann Karmanos Cancer Institute is pleased to announce the launch of a Diversity and Inclusion Committee.

Evotec SE announced that its Seattle-based subsidiary, Just - Evotec Biologics, Inc., received a grant from the Bill & Melinda Gates Foundation as part of the COVID-19 Therapeutics Accelerator to enable the development and production of monoclonal antibody candidates for the prevention of severe COVID-19 in vulnerable populations in low and middle income countries.

The 51st Zhangshu National TCM Materials and Pharmaceuticals Trade Fair sponsored by the China Association of Traditional Chinese Medicine opened in Zhangshu, a country-level city in east China’s Jiangxi Province on Friday.

XPhyto Therapeutics Corp., a next-generation bioscience company, is pleased to announce an update on its third-party contract development programs.

OraSure Technologies, Inc. announced its DNA Genotek subsidiary has received Emergency Use Authorization from the U.S. Food and Drug Administration for the use of DNA Genotek’s OMNIgene®·ORAL saliva collection and stabilization device in COVID-19 testing.

OneOncology Research Network Will Enhance Practices’ High-Quality Clinical Trials Programs While Improving Patients’ Access to Innovative Oncology Therapies

At the virtual 19th Human Proteome Organization World Congress, Bruker Corporation announced that Melvin A. Park and Oliver Raether were awarded the HUPO Science and Technology Award for the commercialization of Trapped Ion Mobility Spectrometry and the Parallel Accumulation Serial Fragmentation method.